Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Grifols ADR Representing One Non-Voting Ord Shs Class B GRFS

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:GRFS)

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

GlobeNewswire October 29, 2024

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

GlobeNewswire October 22, 2024

The Schall Law Firm Is Looking Into Grifols SA For Possible Securities Related Improprieties And Stockholders Are Invited To Reach Out

Accesswire September 6, 2024

Grifols S.A. May Have Committed Fraud And Investors Are Urged To Contact The Schall Law Firm About An Inquiry

Accesswire September 5, 2024

Grifols SA May Have Committed Securities Fraud And Investors With Losses Should Join The Schall Law Firm's Inquiry

Accesswire September 3, 2024

An Investigation Has Been Launched By The Schall Law Firm Into Grifols S.A.'s Possible Securities Law Violations And Shareholders Can Join

Accesswire September 2, 2024

Grifols SA Is Being Looked Into For Securities Fraud And Investors Should Reach Out To The Schall Law Firm About The Inquiry

Accesswire September 1, 2024

The Schall Law Firm Wants The Public To Participate In An Investigation Into Grifols S.A.'s Possible Securities Law Violations

Accesswire August 31, 2024

Grifols SA May Have Committed Securities Fraud And Stakeholders Are Invited To Join The Schall Law Firm's Inquiry

Accesswire August 30, 2024

Bullboard Posts (NDAQ:GRFS)

INFY, TCOM, GRFS, BYU, GBDC showing five-day upward surge

NEWS: $GRFS INFY, TCOM, GRFS, BYU, GBDC showing five-day upward surge2024-08-30 10:45:03 ET Infosys Ltd (INFY) INFY is trading UP for...
whytestocks - August 30, 2024

Spanish Healthcare Firm Grifols Hit With New Gotham City's S

Just In: $GRFS Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency...
whytestocks - March 6, 2024

PANW, U, NOVA, GRFS, ONON showing five-day downward plunge

Breaking News: $GRFS PANW, U, NOVA, GRFS, ONON showing five-day downward plunge2024-03-06 09:47:02 ET Palo Alto Networks Inc (PANW) PANW...
whytestocks - March 6, 2024

Learn to Evaluate (GRFS) using the Charts

BREAKING NEWS: $GRFS Learn to Evaluate (GRFS) using the Charts2024-03-02 09:48:00 ET Stock Traders Daily has produced this trading...
whytestocks - March 2, 2024